Id |
Subject |
Object |
Predicate |
Lexical cue |
T1 |
0-6 |
Var |
denotes |
Mutant |
T2 |
7-10 |
Gene |
denotes |
p53 |
T3 |
11-22 |
PosReg |
denotes |
facilitates |
T4 |
23-49 |
CPA |
denotes |
somatic cell reprogramming |
T5 |
54-62 |
NegReg |
denotes |
augments |
T6 |
67-108 |
CPA |
denotes |
malignant potential of reprogrammed cells |
T7 |
110-113 |
Gene |
denotes |
p53 |
T8 |
114-124 |
Var |
denotes |
deficiency |
T9 |
125-133 |
PosReg |
denotes |
enhances |
T10 |
152-178 |
CPA |
denotes |
somatic cell reprogramming |
T11 |
254-267 |
Var |
denotes |
mutated forms |
T12 |
271-274 |
Gene |
denotes |
p53 |
T13 |
275-279 |
PosReg |
denotes |
gain |
T14 |
286-296 |
MPA |
denotes |
activities |
T15 |
404-408 |
PosReg |
denotes |
gain |
T16 |
412-420 |
MPA |
denotes |
function |
T17 |
440-447 |
Var |
denotes |
mut-p53 |
T18 |
464-472 |
PosReg |
denotes |
enhanced |
T19 |
495-516 |
CPA |
denotes |
reprogramming process |
T21 |
571-579 |
MPA |
denotes |
activity |
T20 |
583-590 |
Var |
denotes |
mut-p53 |
T22 |
599-610 |
Reg |
denotes |
alterations |
T23 |
618-659 |
CPA |
denotes |
characteristics of the reprogrammed cells |
T27 |
748-768 |
MPA |
denotes |
pluripotent capacity |
T24 |
808-814 |
Var |
denotes |
mutant |
T25 |
815-818 |
Gene |
denotes |
p53 |
T26 |
819-823 |
NegReg |
denotes |
lost |
T28 |
844-853 |
Reg |
denotes |
gave rise |
T29 |
857-873 |
CPA |
denotes |
malignant tumors |
T30 |
1054-1072 |
MPA |
denotes |
oncogenic activity |
T34 |
1089-1103 |
PosReg |
denotes |
overexpression |
T31 |
1114-1131 |
Var |
denotes |
p53 KO or mut-p53 |
T32 |
1138-1145 |
PosReg |
denotes |
induced |
T33 |
1146-1163 |
CPA |
denotes |
aggressive tumors |
T35 |
1380-1383 |
Gene |
denotes |
p53 |
T36 |
1387-1394 |
Var |
denotes |
mutated |
T37 |
1396-1409 |
CPA |
denotes |
reprogramming |
T38 |
1414-1423 |
Reg |
denotes |
result in |
T39 |
1442-1486 |
CPA |
denotes |
cells with malignant tumor-forming potential |
R1 |
T2 |
T1 |
ThemeOf |
p53,Mutant |
R10 |
T14 |
T13 |
ThemeOf |
activities,gain |
R11 |
T12 |
T11 |
ThemeOf |
p53,mutated forms |
R12 |
T17 |
T15 |
CauseOf |
mut-p53,gain |
R13 |
T16 |
T15 |
ThemeOf |
function,gain |
R14 |
T17 |
T18 |
CauseOf |
mut-p53,enhanced |
R15 |
T19 |
T18 |
ThemeOf |
reprogramming process,enhanced |
R16 |
T21 |
T20 |
ThemeOf |
activity,mut-p53 |
R17 |
T20 |
T22 |
CauseOf |
mut-p53,alterations |
R18 |
T23 |
T22 |
ThemeOf |
characteristics of the reprogrammed cells,alterations |
R19 |
T24 |
T26 |
CauseOf |
mutant,lost |
R2 |
T1 |
T3 |
CauseOf |
Mutant,facilitates |
R20 |
T27 |
T26 |
ThemeOf |
pluripotent capacity,lost |
R21 |
T25 |
T24 |
ThemeOf |
p53,mutant |
R22 |
T24 |
T28 |
CauseOf |
mutant,gave rise |
R23 |
T29 |
T28 |
ThemeOf |
malignant tumors,gave rise |
R24 |
T34 |
T31 |
ThemeOf |
overexpression,p53 KO or mut-p53 |
R25 |
T31 |
T32 |
CauseOf |
p53 KO or mut-p53,induced |
R26 |
T33 |
T32 |
ThemeOf |
aggressive tumors,induced |
R27 |
T30 |
T31 |
ThemeOf |
oncogenic activity,p53 KO or mut-p53 |
R28 |
T35 |
T36 |
ThemeOf |
p53,mutated |
R29 |
T36 |
T37 |
CauseOf |
mutated,reprogramming |
R3 |
T4 |
T3 |
ThemeOf |
somatic cell reprogramming,facilitates |
R30 |
T37 |
T38 |
CauseOf |
reprogramming,result in |
R31 |
T39 |
T38 |
ThemeOf |
cells with malignant tumor-forming potential,result in |
R4 |
T1 |
T5 |
CauseOf |
Mutant,augments |
R5 |
T6 |
T5 |
ThemeOf |
malignant potential of reprogrammed cells,augments |
R6 |
T7 |
T8 |
ThemeOf |
p53,deficiency |
R7 |
T8 |
T9 |
CauseOf |
deficiency,enhances |
R8 |
T10 |
T9 |
ThemeOf |
somatic cell reprogramming,enhances |
R9 |
T11 |
T13 |
CauseOf |
mutated forms,gain |